[HTML][HTML] Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach
TH Kim, IH Kim, SJ Kang, M Choi, BH Kim… - Journal of gastric …, 2023 - ncbi.nlm.nih.gov
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …
is the 4th gastric cancer guideline published in Korea which is the revised version of …
[HTML][HTML] Anticancer activities of TCM and their active components against tumor metastasis
K Wang, Q Chen, Y Shao, S Yin, C Liu, Y Liu… - Biomedicine & …, 2021 - Elsevier
Abstract Traditional Chinese Medicine (TCM) has the characteristics of multiple targets,
slight side effects and good therapeutic effects. Good anti-tumor effects are shown by …
slight side effects and good therapeutic effects. Good anti-tumor effects are shown by …
[HTML][HTML] Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
S Ouyang, H Li, L Lou, Q Huang, Z Zhang, J Mo, M Li… - Redox biology, 2022 - Elsevier
Chemotherapy is still one of the principal treatments for gastric cancer, but the clinical
application of 5-FU is limited by drug resistance. Here, we demonstrate that ferroptosis …
application of 5-FU is limited by drug resistance. Here, we demonstrate that ferroptosis …
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro …
X Zhang, H Liang, Z Li, Y Xue, Y Wang, Z Zhou… - The Lancet …, 2021 - thelancet.com
Background The optimal perioperative chemotherapeutic regimen for locally advanced
gastric cancer remains undefined. We evaluated the efficacy and safety of perioperative and …
gastric cancer remains undefined. We evaluated the efficacy and safety of perioperative and …
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO …
Background Patients with advanced gastric or gastro-oesophageal junction cancer
refractory to, or intolerant of, two or more previous regimens of chemotherapy have a poor …
refractory to, or intolerant of, two or more previous regimens of chemotherapy have a poor …
Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation
Y Luo, S Zheng, Q Wu, J Wu, R Zhou, C Wang, Z Wu… - Autophagy, 2021 - Taylor & Francis
Chemotherapy is currently the main treatment for unresectable or advanced postoperative
gastric cancers. However, its efficacy is negatively affected by the occurrence of …
gastric cancers. However, its efficacy is negatively affected by the occurrence of …
[HTML][HTML] Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study
Background Preoperative evaluation of the number of lymph node metastasis (LNM) is the
basis of individual treatment of locally advanced gastric cancer (LAGC). However, the …
basis of individual treatment of locally advanced gastric cancer (LAGC). However, the …
Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
Background China has experienced a remarkable epidemiological and demographic
transition during the past three decades. Far less is known about this transition at the …
transition during the past three decades. Far less is known about this transition at the …
[HTML][HTML] Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or …
N Boku, MH Ryu, K Kato, HC Chung, K Minashi… - Annals of …, 2019 - Elsevier
Background Nivolumab is approved as an option for third-or later-line treatment of advanced
gastric/gastroesophageal junction (G/GEJ) cancer in several countries after ATTRACTION-2 …
gastric/gastroesophageal junction (G/GEJ) cancer in several countries after ATTRACTION-2 …
Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality
Background & Aims It is not clear whether screening for gastric cancer by upper endoscopy
or upper gastrointestinal (UGI) series examinations (looking at the upper and middle …
or upper gastrointestinal (UGI) series examinations (looking at the upper and middle …